Genvoya tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBDT4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,008
Award facts
- Contract value 100% obligated
- $29,007.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,007.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for Genvoya Tablet UU 30S, a prescription antiretroviral medication used in HIV treatment. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill federal procurement requirements through open competition, with delivery orders ranging from small transactions to substantial orders exceeding $45,000. This particular award reflects AmerisourceBergen's ongoing role as a preferred vendor within the DLA's pharmaceutical supply chain supporting military and veteran healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FBDT4?
SPE2DB25FBDT4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FBDT4 worth?
The government has obligated $29,008 on SPE2DB25FBDT4.
Is contract SPE2DB25FBDT4 an order under another contract?
Yes. SPE2DB25FBDT4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBDT4 competed?
The extent of competition for SPE2DB25FBDT4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award